Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice.
about
Regulation of transforming growth factor-β1-driven lung fibrosis by galectin-3Growth factor signaling in lung morphogenetic centers: automaticity, stereotypy and symmetryPaclitaxel modulates TGFbeta signaling in scleroderma skin grafts in immunodeficient mice.Role of Bone Marrow-Derived Fibroblasts in Renal FibrosisThe Contribution of Peroxisome Proliferator-Activated Receptor Gamma to Cutaneous Wound HealingKey Fibrogenic SignalingBleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: a model for "active" diseaseMAP3K19 Is a Novel Regulator of TGF-β Signaling That Impacts Bleomycin-Induced Lung Injury and Pulmonary FibrosisMyofibroblasts: trust your heart and let fate decide.Smad3 signaling activates bone marrow-derived fibroblasts in renal fibrosisPulmonary fibrosis: pathogenesis, etiology and regulationInhalation of carbon black nanoparticles aggravates pulmonary inflammation in micePulmonary fibrosis in response to environmental cues and molecular targets involved in its pathogenesisInhibitor of differentiation 1 promotes endothelial survival in a bleomycin model of lung injury in miceSmad2 and Smad3 play different roles in rat hepatic stellate cell function and alpha-smooth muscle actin organizationPeriostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis.Lens-specific expression of TGF-beta induces anterior subcapsular cataract formation in the absence of Smad3Fibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosisTNF-alpha induces TGF-beta1 expression in lung fibroblasts at the transcriptional level via AP-1 activation.Regulation of transforming growth factor-beta1 (TGF-β1)-induced pro-fibrotic activities by circadian clock gene BMAL1.Cellular mechanisms of tissue fibrosis. 8. Current and future drug targets in fibrosis: focus on Rho GTPase-regulated gene transcription.Epithelial origin of myofibroblasts during fibrosis in the lung.Smad3 knock-out mice as a useful model to study intestinal fibrogenesisRepetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis.Ingredients of Huangqi decoction slow biliary fibrosis progression by inhibiting the activation of the transforming growth factor-beta signaling pathway.Transforming growth factor-beta and fibrosisTransforming growth factor-beta/Smad3 signalling regulates inflammatory responses in a murine model of contact hypersensitivity.Tenascin-C deficiency attenuates TGF-ß-mediated fibrosis following murine lung injurySmad2 protects against TGF-beta/Smad3-mediated renal fibrosis.Dissection of the mechanism of traditional Chinese medical prescription-Yiqihuoxue formula as an effective anti-fibrotic treatment for systemic sclerosis.Role of Smad2/3 and p38 MAP kinase in TGF-β1-induced epithelial-mesenchymal transition of pulmonary epithelial cellsIncreased constitutive αSMA and Smad2/3 expression in idiopathic pulmonary fibrosis myofibroblasts is KCa3.1-dependent.Adaptive and maladptive effects of SMAD3 signaling in the adult heart after hemodynamic pressure overloadingScleroderma and Smads: dysfunctional Smad family dynamics culminating in fibrosis.Regulation of transforming growth factor-β1-dependent integrin β6 expression by p38 mitogen-activated protein kinase in bile duct epithelial cellsLow-dose paclitaxel ameliorates pulmonary fibrosis by suppressing TGF-β1/Smad3 pathway via miR-140 upregulation.Coordinated regulation of extracellular matrix synthesis by the microRNA-29 family in the trabecular meshworkBlocking follistatin-like 1 attenuates bleomycin-induced pulmonary fibrosis in mice.Natural killer T (NKT) cells attenuate bleomycin-induced pulmonary fibrosis by producing interferon-gamma.Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma.
P2860
Q24624887-CF22C404-1546-4C5D-9686-6D139A3941EDQ24795748-CFACDA6A-B227-4D51-8638-C0F1F8B5CBC3Q24811751-3D91D29C-0DD6-4A6E-A90E-2259426FC591Q26768585-1657D9CD-783B-44FB-9214-CDE66A08FEBAQ26865930-7606A12B-08B1-4F4D-8D76-5027143FA5CEQ26995788-2385F17F-13C3-46AA-B560-39120AE1E1B0Q27333940-44FEAAF5-EFDA-4E20-AB57-34BCB7F0D2BFQ27348347-0BED5CCD-9A2B-4129-8444-C95419112825Q27692541-7602A161-234E-4860-95BB-CACBF1F97E49Q28235663-A1A92E58-B22E-4FBF-8CC9-6CC2B207D008Q28388425-D71FD1E6-21B5-4706-80AB-5E3F76F9241CQ28391009-5A9F51CD-2690-426F-A60D-064E8775DEFCQ28394670-C5211FCF-2126-41C2-85B4-2ACD9E337F4DQ28506363-FF8FBD2A-204F-4263-BED0-2085DB4C9832Q28567374-E0AAA54F-D3DA-4327-B580-F37D77BE22A5Q30415751-220B20DC-DF40-4510-9A0E-D6947F7516CAQ33609106-7F0F1D38-BF7C-4B27-8252-FC4FC02A9BF5Q33698776-2E600F9B-268E-463A-BCF3-671B7CD44E8BQ33793939-214236D4-0F7E-4951-B15A-8C424F669F7DQ33816685-057D4EB9-7D4B-47EE-8984-432A1421D69AQ33840143-72A70964-36E5-466F-B385-B9BA9B000585Q33996286-FAB4CD63-7B53-4A4D-B9D9-32A2A8108AB3Q34013157-3AFB034F-BEB8-47A3-97CB-296065EB9006Q34212686-CF9DF2AD-3F98-4BFA-81BD-4C111E2A6417Q34218427-C216EED5-886F-4ADF-8F52-BEFA6A1E40A1Q34232534-266BAA15-6CD1-431F-AA66-796AEEBD9974Q34401282-2A41AD68-9785-4096-880B-82A6B3650B59Q34426045-D0D6EE2E-9DFF-4283-B59F-75DAF5890167Q34455322-981CDD97-CCAF-446D-A0F9-DDF8B828099AQ34485231-25170AFB-EBB7-4912-B48B-69CD1F103EF7Q34593997-D8315445-B0B3-4C68-9A83-86614651EDA0Q34677065-DFCDA66D-0C09-4F5F-B717-2C1235AD738DQ34722251-DEDCDFF2-2BD5-4603-B5A3-73178FFCF54CQ34747455-BE1A6FBF-BDC9-45F6-B628-0802F37CDC17Q34868170-470294E7-0AD2-4B85-B0E2-A065884297E3Q34962663-6A783FB6-4D56-4304-89BA-30070AB76E2DQ35027590-A939B64C-3854-460F-B37D-F7435BAB3BFEQ35064880-AF8B2BE2-5217-4046-9DC7-DAA9761182FEQ35085377-C85E8697-27C8-4402-BEE2-8D665F56E446Q35102837-6B1438B0-6660-4DD5-B569-D0ED255D07B8
P2860
Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice.
@en
Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice.
@nl
type
label
Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice.
@en
Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice.
@nl
prefLabel
Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice.
@en
Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice.
@nl
P2093
P2860
P1476
Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice.
@en
P2093
David Warburton
Jingsong Zhao
Joshua P Frederick
Michael B Datto
Pablo Bringas
Xiao-Fan Wang
Yan-Ling Wang
P2860
P304
P356
10.1152/AJPLUNG.00151.2001
P577
2002-03-01T00:00:00Z